NCT04028362View on ClinicalTrials.gov

Neuromuscular Blockade in the Intentive Care Unit, an Observational Study.

CompletedOBSERVATIONAL
Enrollment

282

Participants

Timeline

Start Date

November 2, 2019

Primary Completion Date

April 1, 2020

Study Completion Date

April 1, 2020

Conditions
Critical CareMechanical VentilationNeuromuscular Blockade
Interventions
DRUG

Neuromuscular Blocking Agents

Patient who will receive neuromuscular blockade will be follow during their ICU lenght stay.

Trial Locations (11)

37044

CHRU Bretonneau, Tours

44000

CHU Nantes, Nantes

72037

CH Le Mans, Le Mans

78157

CH de Versailles, Le Chesnay

85925

CHD Les Oudairies, La Roche-sur-Yon

94270

CHU Kremlin-Bicetre, Le Kremlin-Bicêtre

95100

CH d'Argenteuil, Argenteuil

95303

CH de Pontoise, Pontoise

Unknown

CHU Nimes, Nîmes

CHR Orléans, Orléans

CHU La Pitié Salpétrière, Paris

All Listed Sponsors
lead

French Society for Intensive Care

OTHER

NCT04028362 - Neuromuscular Blockade in the Intentive Care Unit, an Observational Study. | Biotech Hunter | Biotech Hunter